Eisai Company, Ltd. Introduces “Hotmin(R)” for Improving Peripheral Blood Circulation

Tokyo, Sept 3, 2008 (JCN Newswire) - Eisai Co., Ltd. (Headquarters: Tokyo, President & CEO: Haruo Naito) announced today that it will launch a new over-the-counter drug “Hotmin(R)” on Tuesday, September 16. This new drug is designed to improve the peripheral blood circulation, and thereby relieve symptoms of coldness in extremities and stiff shoulders.

MORE ON THIS TOPIC